Establishment of a reference standard for epimedin C isolated from Herba Epimedii by mass-balance
Main Article Content
Abstract
Herba Epimedii comprises the dried aerial parts of various Epimedium species (family Berberidaceae). This medicinal material is widely recognized for its pharmacological activities, including sexual function enhancement, anti-osteoporotic, cardiovascular protective, anti-inflammatory, antioxidant, and immunomodulatory effects. Epimedin C is a primary bioactive constituent and is mandated as a reference standard for the qualitative and quantitative analysis of Herba Epimedii in the Vietnamese Pharmacopoeia V. Consequently, the development of a cost-effective, domestic Epimedin C reference standard is critical for the rigorous quality control of this botanical drug. In this study, 6.5 g of Epimedin C was isolated and purified from 5 kg of Herba Epimedii raw material. The structural integrity was confirmed via spectroscopic techniques (1H and 13C-NMR, IR) and HPLC-DAD profiling. The chromatographic purity was determined to be 98.2% using the area normalization method at a test concentration of 1.0 mg/mL, while the total volatile content was measured at 5.0% via Thermogravimetric Analysis (TGA). Finally, by applying the mass balance approach to account for all impurities, the label-assigned content for 125 vials of the Epimedin C reference standard was established as 93.3 ± 0.44% (k = 2).
Article Details
Keywords
Epimedin C, Herba Epimedii, isolation, mass-balance, reference standard
References
2. Ziying Huang and et al (2026), Epimedium: Medicinal plant resources, chemical constituents, pharmacological actions, and biosynthesis of prenylated flavonol glycosides, Industrial Crops and Products, Volume 245, Article: 123320.
3. Fazila Zulfiqara and et al (2017), Prenylated flavonol glycosides from Epimedium 2 grandiflorum: cytotoxicity and evaluation against 3 inflammation and metabolic disorder, Phytochemistry Letters Volume 20, Pages: 160-167.
4. Vietnam Pharmacopoeia Council, Ministry of Health (2019), Epimedium monograph, Vietnam Pharmacopoeia V, Volume II, Medical Publishing House, Hanoi, 1134-1135.
5. Chinese Pharmacopoeia Commission-Ministry of Health, The People of Republic of China Pharmacopoeia, People’s Medical Publishing House; Volumn Ia, 2020:184-186
6. Nguyen Lam Hong et al. (2026), Establishment of icariin standard isolated from Herba epimedii by mass balance method, Journal of Medicine and Pharmacy No. 70, February 2026, 84-94.
7. Nguyen Van Hoang et al. (2017), Isolation and establishment of epimedin C standard from Herba Epimedii, Ho Chi Minh City Medical Research, Supplement Vol. 21, No. 1, 2017, 395-400.
8. Juntao Li and et al (2022), Isolation, bioassay and 3D-QSAR analysis of 8-isopentenyl flavonoids from Epimedium sagittatum maxim. as PDE5A inhibitors, Chinese Medicine, Volume 17, article number 147.
9. International Organization for Standardization (2017), Guide 35: Reference materials–Guidance for characterization and assessment of homogeneity and stability, International Organization for Standardization (ISO), Geneva, 114.
10. World Health Organization (2016), The International Pharmacopoeia, Reference Substances and Reference Spectra: Reference substances and reference spectra, World Health Organization.